Business Publications

Topic: RSS Feed
Comments

Monterey Gourmet Foods to Announce First Quarter 2009 Results on May 6, 2009 at 10:00 a.m. Pacific Time

Market Wire, April, 2009

Monterey Gourmet Foods (NASDAQ: PSTA), a manufacturer and marketer of fresh gourmet refrigerated food products, will report its first quarter 2009 financial results on Wednesday, May 6, 2009. The company plans to host a conference call at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) to discuss these results. Eric Eddings, chief executive officer, and Scott Wheeler, chief financial officer, will deliver prepared remarks and conduct a question and answer session.

To listen to the call live, please dial 877-917-3614 at least 10 minutes prior to the start of the conference and mention participant pass code "Monterey." The call is also being webcast live at http://www.montereygourmetfoods.com .

The call will be archived and available for replay for 90 days from the "Investor Relations" section of the company's website at http://www.montereygourmetfoods.com . A telephone replay will be available for 90 days by dialing 800-879-7966. No pass code is required.

About Monterey Gourmet Foods (NASDAQ: PSTA)

Monterey Gourmet Foods manufactures USDA inspected, fresh gourmet refrigerated food products at its integrated 133,000 square foot corporate headquarters, distribution, and manufacturing facilities in Salinas (Monterey County), CA; Kent, WA; and Eugene, OR. Monterey Gourmet Foods has national distribution of its products, which are sold under the brands Monterey Pasta Company, CIBO Naturals, Emerald Valley Kitchen and Sonoma Cheese in more than 11,000 retail and club stores throughout the United States and selected regions of Canada, the Caribbean, Latin America, and Asia Pacific. For more information about Monterey Gourmet Foods, visit www.MontereyGourmetFoods.com .

Company Contacts: Eric Eddings Chief Executive Officer Monterey Gourmet Foods Email Contact Scott Wheeler Chief Financial Officer Monterey Gourmet Foods Email Contact (253) 867-0570 ext. 1105 Investor Relations Contacts: Lippert / Heilshorn & Associates Becky Herrick Email Contact (415) 433-3777

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with Market Wire

  • Your Work Are You Expat Material?

    Are You Expat Material?

    Here are five things to consider before hunting for work overseas.

  • Your Industry Biogen Corners the Social-Media Market For Its Drugs

    Biogen Corners the Social-Media Market For Its Drugs

    On November 2, Biogen Idec updated the prescribing label for its blockbuster multiple sclerosis drug Tysabri (natalizumab) after consultation with the FDA. Aside from acknowledging that the risk of developing progressive multifocal leukoencephalopathy (PML), an often fatal brain infection, increases with longer duration of treatment, no other revisions concerning the risk of PML were required. The fact that this biologic remains a cornerstone treatment for adult patients with relapsing forms of MS -- only the second drug to ever return to U.S. pharmacy shelves after having been withdrawn -- speaks volumes to the growing influence of the worldwide web.

  • Your Money 29 Fees We Hate Most

    29 Fees We Hate Most

    An increasing number of businesses, from hotels to cell phone providers, are advertising bargain prices and then tacking on hidden fees and charges to boost the final cost. Here’s how you can fight back.